Biophytis S.A. (BPTSY)

USD 3.05

(0.0%)

Long Term Debt Summary of Biophytis S.A.

  • Biophytis S.A.'s latest annual long term debt in 2023 was 3.43 Million EUR , down -22.91% from previous year.
  • Biophytis S.A.'s latest quarterly long term debt in 2023 FY was 3.43 Million EUR , down -22.91% from previous quarter.
  • Biophytis S.A. reported annual long term debt of 4.45 Million EUR in 2022, down -25.94% from previous year.
  • Biophytis S.A. reported annual long term debt of 6.01 Million EUR in 2021, up 170.15% from previous year.
  • Biophytis S.A. reported quarterly long term debt of 3.43 Million EUR for 2023 FY, down -22.91% from previous quarter.
  • Biophytis S.A. reported quarterly long term debt of 3.43 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Biophytis S.A. (2023 - 2016)

Historical Annual Long Term Debt of Biophytis S.A. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 3.43 Million EUR -22.91%
2022 4.45 Million EUR -25.94%
2021 6.01 Million EUR 170.15%
2020 2.22 Million EUR -54.81%
2019 4.93 Million EUR -21.69%
2018 6.29 Million USD 0.0%
2017 - USD -100.0%
2016 863.84 Thousand USD 0.0%

Peer Long Term Debt Comparison of Biophytis S.A.

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 83.564%
Evofem Biosciences, Inc. 8000.00 USD -42857.075%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -95.762%
Mesoblast Limited 100.29 Million USD 96.574%
Propanc Biopharma, Inc. 58.64 Thousand USD -5760.247%
Genus plc 228.2 Million USD 98.494%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD -415.128%
ContraFect Corporation 2.21 Million USD -55.501%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -144.956%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 36.67%
MultiCell Technologies, Inc. 36.43 USD -9433240.653%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 93.82%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD -54.383%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -179.768%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 97.931%
Oncotelic Therapeutics, Inc. 1.89 Million USD -81.018%
Skye Bioscience, Inc. 171.23 Thousand USD -1906.988%
Therapeutic Solutions International, Inc. 5512.00 USD -62246.988%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 87.457%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -967.257%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.969%
Halberd Corporation 150 Thousand USD -2191.044%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD -1045.522%
Nuo Therapeutics, Inc. 164.2 Thousand USD -1992.851%
argenx SE 15.35 Million USD 77.618%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 83.081%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -77022.217%
Genscript Biotech Corporation 287.12 Million USD 98.803%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -2620.912%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -1398.779%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -519.659%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -13483.802%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 58.415%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -1193.717%
ONE Bio Corp. 592.19 Thousand USD -480.307%
Reve Technologies, Inc. 1064.00 USD -322885.526%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -2196.955%
Regen BioPharma, Inc. 149.61 Thousand USD -2196.955%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -1396.169%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -2337.281%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -4195.708%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 56.054%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -831.195%
International Stem Cell Corporation 445 Thousand USD -672.262%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 57.834%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -651.984%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -196.001%
PureTech Health plc 18.25 Million USD 81.17%
Coeptis Therapeutics, Inc. 150 Thousand USD -2191.044%
IXICO plc 275 Thousand USD -1149.66%
IntelGenx Technologies Corp. 11.83 Million USD 70.972%
Gelesis Holdings, Inc. 26.3 Million USD 86.938%
CSL Limited 11.23 Billion USD 99.969%
Cellectis S.A. 36.21 Million USD 90.51%